David M. Manyak
Director/Board Member at Molecular Transfer, Inc.
Profile
David M.
Manyak is the founder of gMed., Inc. He is currently the Director at Molecular Transfer, Inc. He was previously the Chief Executive Officer at NovaScreen Biosciences Corp.
from 1993 to 2005, Vice President at Merrill Lynch & Co., Inc. from 1985 to 1990, Vice President at Value Line, Inc. from 1983 to 1985, and EVP-Discovery Alliances & Services Business Unit at Caliper Life Sciences, Inc. from 2009 to 2011.
Dr. Manyak received his undergraduate degree from Brown University and his doctorate from Duke University.
David M. Manyak active positions
Companies | Position | Start |
---|---|---|
Molecular Transfer, Inc.
Molecular Transfer, Inc. BiotechnologyHealth Technology Molecular Transfer, Inc. develops, manufactures and distributes human and mouse stem cell research products and services. It expertise in stem and neural cell culture, along with cutting-edge tools for novel transfection approaches. The firm's services include integrated solution services, stem cell banking, testing services and contract research and development services. The company was founded by Joel Jessee in 2009 and is headquartered in Gaithersburg, MD. | Director/Board Member | - |
Former positions of David M. Manyak
Companies | Position | End |
---|---|---|
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Corporate Officer/Principal | 2011-11-06 |
NovaScreen Biosciences Corp.
NovaScreen Biosciences Corp. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., NovaScreen Biosciences Corp. is a company that develops commercial research and drug discovery devices. The company is based in Hanover, MD. NovaScreen Biosciences was acquired by Caliper Life Sciences, Inc., part of Revvity, Inc. from November 07, 2011 on October 04, 2005 for $30 million. | President | 2005-09-30 |
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Corporate Officer/Principal | 1989-12-31 |
VALUE LINE, INC. | Corporate Officer/Principal | 1984-12-31 |
gMed., Inc.
gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL. | Founder | - |
Training of David M. Manyak
Duke University | Doctorate Degree |
Brown University | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
VALUE LINE, INC. | Consumer Services |
Private companies | 5 |
---|---|
Caliper Life Sciences, Inc.
Caliper Life Sciences, Inc. SemiconductorsElectronic Technology Caliper Life Sciences, Inc. develops, manufactures, and sells labchip systems. It offers microfluids, lab automation, liquid handling, optical imaging technologies, and discovery and development outsourcing solutions. The company was founded by Michael R. Knapp on July 26, 1995 and is headquartered in Hopkinton, MA. | Electronic Technology |
NovaScreen Biosciences Corp.
NovaScreen Biosciences Corp. Miscellaneous Commercial ServicesCommercial Services Part of Revvity, Inc., NovaScreen Biosciences Corp. is a company that develops commercial research and drug discovery devices. The company is based in Hanover, MD. NovaScreen Biosciences was acquired by Caliper Life Sciences, Inc., part of Revvity, Inc. from November 07, 2011 on October 04, 2005 for $30 million. | Commercial Services |
Merrill Lynch & Co., Inc. /Old/
Merrill Lynch & Co., Inc. /Old/ Investment Banks/BrokersFinance Merrill Lynch & Co., Inc. provided wealth management, securities trading and sales, corporate finance and investment banking services. Merrill Lynch was a global trader and underwriter of securities and derivatives across a range of asset classes and serve as a strategic advisor to governments, institutions and individuals worldwide. The company was founded in 1913 and was headquartered in Charlotte, NC. | Finance |
gMed., Inc.
gMed., Inc. BiotechnologyHealth Technology gMed is engaged in providing physicians with information solutions to “Care Better” for their patients and practice. The company provides Digital Charting solutions for Gastroenterology and Cardiology designed to eliminate paper, increase revenues, decrease costs and enhance patient care at the medical office, ambulatory surgery center and hosptial. gMED was founded in 1997 and is located in Weston, FL. | Health Technology |
Molecular Transfer, Inc.
Molecular Transfer, Inc. BiotechnologyHealth Technology Molecular Transfer, Inc. develops, manufactures and distributes human and mouse stem cell research products and services. It expertise in stem and neural cell culture, along with cutting-edge tools for novel transfection approaches. The firm's services include integrated solution services, stem cell banking, testing services and contract research and development services. The company was founded by Joel Jessee in 2009 and is headquartered in Gaithersburg, MD. | Health Technology |
- Stock Market
- Insiders
- David M. Manyak